NASDAQ
Agios Pharmaceuticals, Inc. (AGIO) reported revenue of $54.03M and net income of $-412.78M for FY 2025. The gross profit margin is 78.7% with a net profit margin of -764.0%.
Financial data for AGIO
48.03% YoY
161.27% YoY
160.03% YoY
Annual Income Statement for AGIO
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 |
| Cost of Revenue | $12M | $4M | $10M | $2M | $19M |
| Gross Profit | $43M | $32M | $17M | $13M | -$19M |
| Operating Expenses | $515M | $458M | $409M | $402M | $360M |
| Operating Income | -$472M | -$426M | -$391M | -$389M | -$378M |
| Net Income | -$413M | $674M | -$352M | -$232M | $2B |
| EPS | $-7.12 | $11.86 | $-6.33 | $-4.23 | $-6.36 |
| EBITDA | -$467M | -$420M | -$385M | -$380M | -$338M |
No price data available for this timeframe.